Literature DB >> 14725786

Achieving change in the NHS: a study to explore the feasibility of a home-based cancer chemotherapy service.

Daniel Kelly1, Susie Pearce, Elizabeth Butters, Warren Stevens, Sarah Layzell.   

Abstract

A major focus of current health policy in the United Kingdom is the development of services that meet the public's expectations. To achieve this there is a need to evaluate current provision to ensure that the best use is made of finite resources. The study reported here adopted an interview approach to examine an existing outpatient chemotherapy service, and to consider the feasibility of introducing a home based model. Following a review of literature on this topic data were obtained from in-depth interviews with patients and professionals regarding the present service. These were then combined with an analysis of service contracts and financial estimates. The poor quality of much of the cost-related information limited the conclusions which could be drawn, and emphasised the need for access to more accessible and robust financial information upon which to base change. The study also illustrated the benefits of feasibility studies; especially when cost-effectiveness and patient satisfaction are the driving forces behind proposed changes to clinical services.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725786     DOI: 10.1016/j.ijnurstu.2003.05.002

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  2 in total

1.  Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.

Authors:  François Lüthi; Nadia Fucina; Nathalie Divorne; Brigitte Santos-Eggimann; Christine Currat-Zweifel; Patricia Rollier; Jean-Blaise Wasserfallen; Nicolas Ketterer; Serge Leyvraz
Journal:  Support Care Cancer       Date:  2011-03-08       Impact factor: 3.603

2.  Feasibility and obstacles in home chemotherapy for malignant lymphoma.

Authors:  Yuko Kodama; Masahiro Kami; Koichiro Yuji; Miyoko Kuboya; Tsunehiko Komatsu
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.